The estimated Net Worth of Allan Shaw is at least $6.59 Mille dollars as of 13 January 2017. Allan Shaw owns over 1,389 units of VIVUS stock worth over $6,590 and over the last 9 years Allan sold VVUS stock worth over $0.
Allan has made over 6 trades of the VIVUS stock since 2016, according to the Form 4 filled with the SEC. Most recently Allan exercised 1,389 units of VVUS stock worth $648 on 13 January 2017.
The largest trade Allan's ever made was exercising 1,389 units of VIVUS stock on 13 January 2017 worth over $648. On average, Allan trades about 189 units every 3 days since 2015. As of 13 January 2017 Allan still owns at least 14,126 units of VIVUS stock.
You can see the complete history of Allan Shaw stock trades at the bottom of the page.
Allan's mailing address filed with the SEC is C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW, CA, 94041.
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner e Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: